We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 3 for:    small cell lung cancer BMN 673

Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors

This study has been withdrawn prior to enrollment.
(The pharmaceutical company did not want to follow through with support for the study.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT02537561
First Posted: September 1, 2015
Last Update Posted: February 11, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
BioMarin Pharmaceutical
Information provided by (Responsible Party):
Washington University School of Medicine
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: June 2018 (Final data collection date for primary outcome measure)